AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Matsumoto, S Nishimura, M Kaji, R Sakamoto, T Mezaki, T Shimazu, H Murase, N Shibasaki, H
Citation: S. Matsumoto et al., DYTI mutation in Japanese patients with primary torsion dystonia, NEUROREPORT, 12(4), 2001, pp. 793-795

Authors: Mezaki, T Chinushi, M Washizuka, T Furushima, H Chinushi, Y Ebe, K Okumura, H Aizawa, Y
Citation: T. Mezaki et al., Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis - Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis, INTERN MED, 40(8), 2001, pp. 731-735

Authors: Mezaki, T Matsumoto, S Hamada, C Mukoyama, I Sakamoto, T Mizutani, K Takamatsu, N Shibasaki, H Kaji, R
Citation: T. Mezaki et al., Decreased serum ceruloplasmin and copper levels in cervical dystonia, ANN NEUROL, 49(1), 2001, pp. 138-139

Authors: Mizutani, K Oka, N Kusunoki, S Kaji, R Mezaki, T Akiguchi, I Shibasaki, H
Citation: K. Mizutani et al., Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3, J NEUR SCI, 188(1-2), 2001, pp. 9-11

Authors: Aoki, Y Kodama, M Mezaki, T Ogawa, R Sato, M Okabe, M Aizawa, Y
Citation: Y. Aoki et al., von Recklinghausen disease complicated by pulmonary hypertension, CHEST, 119(5), 2001, pp. 1606-1608

Authors: Chinushi, M Mezaki, T Aoki, Y Nakagawa, I Washizuka, T Aizawa, Y
Citation: M. Chinushi et al., Demonstration of transient entrainment in monomorphic sustained ventricular tachycardia associated with cardiac sarcoidosis, JPN CIRC J, 64(8), 2000, pp. 635-637

Authors: Mezaki, T Kaji, R Brin, MF Hirota-Katayama, M Kubori, T Shimizu, T Kimura, J
Citation: T. Mezaki et al., Combined use of type A and F botulinum toxins for blepharospasm: A double-blind controlled trial, MOVEMENT D, 14(6), 1999, pp. 1017-1020

Authors: Mezaki, T Kaji, R Kimura, J
Citation: T. Mezaki et al., A clinical spectrum, MUSCLE NERV, 22(12), 1999, pp. 1739-1740

Authors: Mezaki, T Kaji, R Hirota, N Kohara, N Kimura, J
Citation: T. Mezaki et al., Treatment of spasticity with muscle afferent block, NEUROLOGY, 53(5), 1999, pp. 1156-1157
Risultati: 1-9 |